| Date | Time | Local Time | Room | Session | Role | Topic |
|---|---|---|---|---|---|---|
| 2020-10-19 | 12:35-13:15 | 2020-10-19,12:35-13:15 | Atrial Fibrillation Week Channel |
Catheter Ablation of Atrial Fibrillation (2) |
Operator | LIve Case |
| 2020-10-21 | 17:00-17:15 | 2020-10-21,17:00-17:15 | Atrial Fibrillation Channel |
Novel Method for Atrial Fibrillation Ablation |
Speaker | Hybrid Approach for the Treatment of Long-Standing Persistent Atrial Fibrillation |
| 2020-10-21 | 17:50-18:10 | 2020-10-21,17:50-18:10 | Atrial Fibrillation Channel |
【Satellite Symposium】Boehringer Ingelheim Satellite Symposium: Debate on the Clinical Value of NOAC Reversal Agents |
Speaker | Should We Give Preference to OACs with Reversal Agents? Cons |
| 2020-10-23 | 20:20-20:40 | 2020-10-23,20:20-20:40 | Interpretation of Clinical Research and Guideline Channel |
【Symposium】Johnson & Johnson Symposium: Interpretation of Scientific Literature |
Speaker | Low-Dose Ibutilide Combined with Catheter Ablation of Persistent Atrial Fibrillation: Procedural Impact and Clinical Outcome |
| 2020-10-24 | 19:00-21:00 | 2020-10-24,19:00-21:00 | Atrial Fibrillation Channel |
【Symposium】Johnson & Johnson Symposium: “Double Safety” |
Discussant |